Member Info for Toukankahmoon

Because profitability is years away and biotech R&D is expensive.

Because we need funding very soon and that could be as low as 20p in order to attract investors.

Because end of P1 is 12 months away.

Because AVA6000 has only had efficacy in a small proportion of a very small clinical trial so far.

Because competitive treatments that will actually prevent cancer rather just delaying it are receiving massive funding and proceeding at pace.

I could go on . . .

Buen

I’m not bashing Avacta, I’m pointing out the stupidity of the rampers fantasy predictions.

Largo

Thanks for reminding me Makes me feel all warm and fuzzy remembering why I’ve sunk £50k into this🤡

Thorn

You of all people know that they can’t do that yet.

. . . such thorough and deep and comprehensive research 🤡

Watching

How many times over the past 2 years have you posted jewels similar to this:

“ Personally I think the next rns

Will be massive news

Buy hold ignore the noise”

. . . and what has happened?

Do shut up stating the bl***din obvious

Whatever you paid yesterday and today you can be relatively optimistic that you will pay less tomorrow. Wasn’t it that venerable sage Timster that predicted 20p placing?

Knot

Obviously need to prefix every post with IMO.

IMO = in my opinion = therefore not necessarily a fact

Thorn

Just like most of the stuff on here.

Obviously need to prefix every post with IMO.

suspect license agreement could have a number of suitors but a takeover although less likely would be Novartis because of CCs previous relationship

LLP

I’m with you. Novartis will be the partner as soon as P1b results published

The agreement with Novartis is paused awaiting P1b results.

Opti

Finally the rampers are seeing it for what it is.

Who would have thought it. After unexpected exceptional results.

Only the science matters

SP is immaterial

Excellent opportunity today to top up. We’re never going to get another chance at this price.

Takeover in final stages but NDA prevents them talking about it.

There Ive saved all you rampers from posting for the rest of the day🤣

FFS LDA there will be no partnerships until P1b shows some decent results

. . . and what good news exactly are you expecting? What significant news did we get that was released at a conference?

NFTs

You are desperate and delusional. No deal can come until P1b initial results come through

NFTs

And what proportion of those participants in the trial showed a significant response? 10% wasn’t it. That just isn’t enough to convince investors.

P1b has to blow that out the water

"we sold the holding in avacta as recent clinical data of its targeted oncology drug (a tumourreleased form of the longstanding chemotherapy drug doxorubicin) was underwhelming. while the better safety profile versus the existing standard of care was as predicted, this counts for very little if the efficacy falls below what was desired. "

For me it’s hard to come up with a different conclusion. We are all just hoping that P1b results turn the tide yes i know it’s phase 1 safety and tolerability trial (which in itself is crazy given the way the mechanism is designed, and is proven, to work) but unless P1b shows it shows marked efficacy in most of the patients, then this will plummet

Goldie

You’ve just proved that you have no I, A or otherwise 🤡

vs

you keep bringing up the virgilio sacchini interview but:

he approached cc after a convention

he had breast cancer patients cured of cancer following treatment with a ****tail including doxorubicin

a large proportion of those patients died in the weeks following of collateral damage to vital organs

alerted to ava6000’s unique targeting he saw this as an excellent alternative treatment

coincidentally p1a results had shown results for mid fap tumours like tnbc

virgilio sacchini was just parroting the specification of ava6000 in the context of how it would revolutionise treatment of his patients.

at that time none of his patients had been treated. they couldn’t have been unless there was some clandestine clinical trial taking place in parallel that we haven’t been told about.

we all want avacta to be successful, but trotting out this rubbish about virgilio sacchini really isn’t helping.